{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:33:39Z","timestamp":1782887619276,"version":"3.54.5"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Cell-free DNA (cfDNA) analysis is a minimally invasive method that can be used to detect genomic abnormalities by directly testing a blood sample. This method is particularly useful for immunosuppressed patients, who are at high risk of complications from tissue biopsy. The cfDNA tumor fraction (TF) varies greatly across cancer type and between patients. Thus, the detection of molecular alterations is highly dependent on the circulating TF. In our study, we aimed to calculate the TF and characterize the copy number aberration (CNA) profile of cfDNA from patients with rare malignancies occurring in immunosuppressed environments or immune-privileged sites. To accomplish this, we recruited 36 patients: 19 patients with non-Hodgkin lymphoma (NHL) who were either human immunodeficiency virus (HIV)-positive or organ transplant recipients, 5 HIV-positive lung cancer patients, and 12 patients with glioma. cfDNA was extracted from the patients\u2019 plasma and sequenced using low-coverage whole genome sequencing (LC-WGS). The cfDNA TF was then calculated using the ichorCNA bioinformatic algorithm, based on the CNA profile. In parallel, we performed whole exome sequencing of patient tumor tissue and cfDNA samples with detectable TFs. We detected a cfDNA TF in 29% of immune-suppressed patients (one patient with lung cancer and six with systemic NHL), with a TF range from 8 to 70%. In these patients, the events detected in the CNA profile of cfDNA are well-known events associated with NHL and lung cancer. Moreover, cfDNA CNA profile correlated with the CNA profile of matched tumor tissue. No tumor-derived cfDNA was detected in the glioma patients. Our study shows that tumor genetic content is detectable in cfDNA from immunosuppressed patients with advanced NHL or lung cancer. LC-WGS is a time- and cost-effective method that can help select an appropriate strategy for performing extensive molecular analysis of cfDNA. This technique also enables characterization of CNAs in cfDNA when sufficient tumor content is available. Hence, this approach can be used to collect useful molecular information that is relevant to patient care.<\/jats:p>","DOI":"10.3389\/fcell.2021.661272","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T03:55:37Z","timestamp":1634356537000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations"],"prefix":"10.3389","volume":"9","author":[{"given":"Amira","family":"Bouzidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Labreche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Veyri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me Alexandre","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Touat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Sanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Davi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erell","family":"Guillerm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Jouannet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Charlotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Choquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Bo\u00eblle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Autran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Lacorte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Spano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Coulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the IDEATION study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1681\/ASN.2018090906","article-title":"Overall and site-specific cancer mortality in patients on dialysis and after kidney transplant.","volume":"30","author":"Au","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers.","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early\u2013 and late-stage human malignancies.","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med. 6:224ra24."},{"key":"B41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41408-018-0111-6","article-title":"Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.","volume":"8","author":"Bohers","year":"2018","journal-title":"Blood Cancer J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification.","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer.","volume":"30","author":"Carter","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"584095","DOI":"10.3389\/fonc.2020.584095","article-title":"DNA copy number changes in diffuse large b cell lymphomas.","volume":"10","author":"Cascione","year":"2020","journal-title":"Front. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor.","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1158\/1078-0432.CCR-18-1593","article-title":"Low-pass whole-genome sequencing of circulating cell-free dna demonstrates dynamic changes in genomic copy number in a squamous lung cancer clinical cohort.","volume":"25","author":"Chen","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jvir.2019.07.016","article-title":"Percutaneous lung biopsy in immunocompromised pediatric patients.","volume":"31","author":"Cleveland","year":"2020","journal-title":"J. Vasc. Interv. Radiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gks1443","article-title":"Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation.","volume":"41","author":"Costello","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40291-017-0287-7","article-title":"The role of beaming and digital PCR for multiplexed analysis in molecular oncology in the era of next-generation sequencing.","volume":"21","author":"Denis","year":"2017","journal-title":"Mol. Diagn. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner.","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1101\/gr.180281.114","article-title":"TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data.","volume":"24","author":"Ha","year":"2014","journal-title":"Genome Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1101\/gr.137570.112","article-title":"Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer.","volume":"22","author":"Ha","year":"2012","journal-title":"Genome Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1093\/cid\/ciaa1016","article-title":"Deaths attributable to cancer in the United States HIV population during 2001-2015.","volume":"72","author":"Horner","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/ijc.30531","article-title":"Cancer risks after solid organ transplantation and after long-term dialysis.","volume":"140","author":"Hortlund","year":"2017","journal-title":"Int. J. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.21037\/tlcr.2016.08.06","article-title":"Pros: Can tissue biopsy be replaced by liquid biopsy?","volume":"5","author":"Ilie","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41598-020-57624-4","article-title":"Determination of somatic mutations and tumor mutation burden in plasma by capp-seq during afatinib treatment in nsclc patients resistance to osimertinib.","volume":"10","author":"Ishii","year":"2020","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants.","volume":"15","author":"Kim","year":"2018","journal-title":"Nat. Methods"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform.","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","article-title":"Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.","volume":"10","author":"Lopez","year":"2019","journal-title":"Nat. Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e9323","DOI":"10.15252\/emmm.201809323","article-title":"Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients.","volume":"10","author":"Mouliere","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1158\/1078-0432.CCR-20-3083","article-title":"TERT promoter mutation analysis for blood-based diagnosis and monitoring of gliomas.","volume":"27","author":"Muralidharan","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.","volume":"20","author":"Newman","year":"2014","journal-title":"Nat. Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/1129729817747543","article-title":"Complications and adequacy of transplant kidney biopsies: a comparison of techniques.","volume":"19","author":"Plattner","year":"2018","journal-title":"J. Vasc. Access"},{"key":"B29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/gcc.22460","article-title":"Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer.","volume":"56","author":"Qiu","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13073-020-00735-4","article-title":"Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma.","volume":"12","author":"Raman","year":"2020","journal-title":"Genome Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S1470-2045(15)70106-3","article-title":"Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study.","volume":"16","author":"Roschewski","year":"2015","journal-title":"Lancet Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1182\/blood-2016-05-719641","article-title":"Diffuse large B-cell lymphoma genotyping on the liquid biopsy.","volume":"129","author":"Rossi","year":"2017","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and Pathogenesis of diffuse large b-cell lymphoma.","volume":"378","author":"Schmitz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11904-011-0085-5","article-title":"Cancer screening in patients infected with HIV.","volume":"8","author":"Sigel","year":"2011","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.2","article-title":"Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences.","volume":"4","author":"Soneson","year":"2015","journal-title":"F1000Research"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1158\/1078-0432.CCR-12-2347","article-title":"Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models.","volume":"18","author":"Spoerke","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/annonc\/mdv019","article-title":"Genetic lesions in diffuse large B-cell lymphomas.","volume":"26","author":"Testoni","year":"2015","journal-title":"Ann. Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1158\/1078-0432.CCR-17-0675","article-title":"Shallow whole genome sequencing on circulating cell-free dna allows reliable noninvasive copy-number profiling in neuroblastoma patients.","volume":"23","author":"Van Roy","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.lungcan.2021.05.013","article-title":"Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA).","volume":"157","author":"Wislez","year":"2021","journal-title":"Lung Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJMra1615896","article-title":"HIV-associated cancers and related diseases.","volume":"378","author":"Yarchoan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/jmedgenet-2018-105272","article-title":"Whole-genome sequencing analysis of CNV using low-coverage and paired-end strategies is efficient and outperforms array-based CNV analysis.","volume":"55","author":"Zhou","year":"2018","journal-title":"J. Med. Genet."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.661272\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T03:55:39Z","timestamp":1634356539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.661272\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":44,"alternative-id":["10.3389\/fcell.2021.661272"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.661272","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"article-number":"661272"}}